Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 6, 2015
Pharmacy Choice - News - Front Page Healthcare News - July 6, 2015

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/6/15 - Alexion Gets CHMP Positive Opinions for Strensiq (asfotase alfa) and Kanuma (sebelipase alfa) in the European Union [Professional Services Close - Up]
Alexion Pharmaceuticals reported that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted positive opinions recommending marketing authorization of Strensiq and Kanuma. Based on the CHMP's positive recommendations, final decisions from the European Commission are expected in the third quarter of 2015,...
7/6/15 - Alexion Updates on CHMP Positive Opinions for Strensiq (asfotase alfa) and Kanuma (sebelipase alfa) in the European Union [Manufacturing Close - Up]
Alexion Pharmaceuticals reported that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted positive opinions recommending marketing authorization of Strensiq and Kanuma. Based on the CHMP's positive recommendations, final decisions from the European Commission are expected in the third quarter of 2015,...
7/6/15 - European Commission Approves Bristol-Myers Squibb's Opdivo nivolumab, the First and Only PD-1 Checkpoint Inhibitor Approved in Europe, for Both...
By a News Reporter-Staff News Editor at Biotech Business Week Bristol-Myers Squibb Company announced that the European Commission has approved Opdivo, a PD-1 immune checkpoint inhibitor, for the treatment of advanced melanoma in adults, regardless of BRAF status. Opdivo is the only PD-1 immune checkpoint inhibitor to receive an accelerated assess
7/6/15 - FDA Approves Technology Upgrade for Recipients of First Commercially Available Cochlear Implant
By a News Reporter-Staff News Editor at Pharma Business Week Cochlear Limited, the global leader in implantable hearing solutions, announced that the U.S. Food and Drug Administration has approved the Cochlear? Nucleus 6 Sound Processor for use with the Nucleus 22 Cochlear Implant, giving those who have worn cochlear implants from the beginning
7/6/15 - Findings from Central Hospital Broaden Understanding of Hepatitis B Virus (Elevated mean platelet volume is associated with poor short-term outcomes...
By a News Reporter-Staff News Editor at Hepatitis Weekly Investigators publish new report on Liver Diseases and Conditions. According to news reporting out of Tianjin, People's Republic of China, by NewsRx editors, research stated, "It has been shown that mean platelet volume can be used as a prognostic biomarker in some chronic diseases.
7/6/15 - Gilead Submits New Drug Application to U.S. FDA for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide... [Health & Beauty Close - Up]
FDA for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide. Gilead Sciences reported that it has submitted a New Drug Application to the U.S. Food and Drug Administration for an investigational, once-daily single tablet regimen that combines Gilead's emtricitabine 200 mg and tenofovir alafenamide 25 mg wit
7/6/15 - INVEGA TRINZA?, First and Only Four-Times-A-Year Treatment for Schizophrenia, Now Commercially Available
By a News Reporter-Staff News Editor at Clinical Trials Week The first schizophrenia treatment to be taken just four times a year- with dosing measured in seasons, not days- is now available in the United States. Janssen Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration recently approved INVEGA TRINZA? under Priority Re
7/6/15 - Market Research Rerports Inc: Global Biosimilars Market Value Could Hit $55 Billion by 2020, Finds New Report
Market Research Reports, Inc. has announced the addition of "BIOSIMILARS- Regulatory Framework and Pipeline Analysis" research report to their website http://www.MarketResearchReports.com. The global biosimilars market value is expected to reach $20 billion by the end of 2015 and could hit $55 billion by 2020, with growth primarily driven by a prom
7/6/15 - MarketsandMarkets: Interventional Cardiology and Peripheral Vascular Devices Market worth $26.72 Billion by 2019
The global interventional cardiology and peripheral vascular devices market is expected to reach $26.72 Billion by 2019 from $18.73 Billion in 2014, at a CAGR of 7.4% from 2014 to 2019.. Based on geography, the global interventional cardiology and peripheral vascular devices market is segmented into North America, Europe, Asia, and the Rest of the
7/6/15 - New Neuroradiology Data Have Been Reported by Investigators at University of Miami (Statin Therapy Does Not Affect the Radiographic and Clinical...
New Neuroradiology Data Have Been Reported by Investigators at University of Miami. According to news reporting from Miami, Florida, by NewsRx journalists, research stated, "Imaging and clinical outcomes of high-risk patients with TIA and stroke who underwent acute statin treatment were assessed. The news correspondents obtained a quote from the re
7/6/15 - New Online Community, Quitter's Circle, Helps Smokers Trade Cigarettes for Real-Time Support
By a News Reporter-Staff News Editor at Pharma Business Week The American Lung Association and Pfizer announced the launch of Quitter's Circle, a mobile app and online community designed to help smokers face common obstacles associated with quitting through educational, social and financial support. Albert Rizzo, Senior Medical Advisor of the Ame
7/6/15 - New Procedure at Dominican Hospital Allows for Heart Valve Replacement Without Opening Chest
By a News Reporter-Staff News Editor at Cardiovascular Week Dignity Health Dominican Hospital now offers the groundbreaking Transcatheter Aortic Valve Replacement procedure, which allows for heart valve replacement without opening a patient's chest. Dominican is one of the select providers in the nation, and the only hospital in the entire Monter
7/6/15 - par8o Partners with The Institute for Relevant Clinical Data Analytics [Health & Beauty Close - Up]
par8o reported that The Institute for Relevant Clinical Data Analytics has partnered with them to integrate clinical decision support at the point of care. According to a media release, IRCDA's participating member hospitals include Boston Children's Hospital, Brigham and Women's Hospital, Florida Hospital, and Sahlgrenska Hospital in Sweden. par8o
7/6/15 - PeriCoach, New FDA-Approved Pelvic Floor Training System For Women, Now Available
By a News Reporter-Staff News Editor at Pharma Business Week The millions of women who experience bladder leakage now have a new option to strengthen and tone away their problem instead of covering it up with pads. The PeriCoach System is a discreet device and smartphone app that helps women perform at-home pelvic floor muscle training, exercises
7/6/15 - Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline
By a News Reporter-Staff News Editor at Pharma Business Week Pfizer Inc. announced that it has entered into an agreement with GlaxoSmithKline to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for a total consideration of approximately $130 million. This transaction will add two high-quality and complementary vaccines to
7/6/15 - Reports Outline Atrial Fibrillation Findings from Taipei Veterans General Hospital (Incidence and risk factors for new-onset atrial fibrillation...
Reports Outline Atrial Fibrillation Findings from Taipei Veterans General Hospital. According to news reporting from Taipei, Taiwan, by NewsRx journalists, research stated, "Atrial fibrillation is prevalent in end-stage renal disease patients and negatively impacts patient outcomes. The news correspondents obtained a quote from the research from...
7/6/15 - Researchers from Food and Drug Administration Report New Studies and Findings in the Area of Health and Medicine (Comparison of content of FDA...
By a News Reporter-Staff News Editor at Clinical Trials Week Research findings on Health and Medicine are discussed in a new report. According to news reporting originating in Silver Spring, Maryland, by NewsRx journalists, research stated, "To describe the content of non-public complete response letters issued by the US Food and Drug Administrat
7/6/15 - Sarepta Therapeutics Taps Henri Termeer as Advisor to the Company [Health & Beauty Close - Up]
Sarepta Therapeutics reported that Henri Termeer, former CEO of Genzyme, will be a key advisor to the Company. "I am honored to have Henri Termeer, a pioneer of rare disease companies, serve as an advisor as we seek FDA approval for our lead product candidate and build a rare disease organization," said Edward Kaye, M.D., Sarepta's interim chief e
7/6/15 - Siemens - Value-based Healthcare Delivery: Building Healthcare Business Models
Release date- 02072015- Building Healthcare Business Models. The following case studies from the United States, Sweden, and Germany provide insights into possible solutions to master the challenges healthcare systems are facing. United States: From Fee-for-service Models to Value-based Purchasing.
7/6/15 - Strensiq Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia
Alexion Pharmaceuticals, Inc. announced today that Japan's Ministry of Health, Labour and Welfare approved the Company's New Drug Application for the use of Strensiq as a treatment for patients in Japan with hypophosphatasia, a life-threatening, ultra-rare metabolic disorder. Strensiq, a bone-targeted enzyme replacement therapy, is the first the
7/6/15 - Strensiq (asfotase alfa) Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc. announced today that Japan s Ministry of Health, Labour and Welfare approved the Company s New Drug Application for the use of Strensiq as a treatment for patients in Japan with hypophosphatasia, a life-threatening, ultra-rare metabolic disorder. Strensiq, a bone-targeted enzyme replacement therapy, is the fir
7/6/15 - Studies from King's College in the Area of Antibiotics Described (Antibiotics: the changing regulatory and pharmaceutical industry paradigm)
For more information on this research see: Antibiotics: the changing regulatory and pharmaceutical industry paradigm. Journal of Antimicrobial Chemotherapy, 2015; 70: 1281-1284. Journal of Antimicrobial Chemotherapy can be contacted at: Oxford Univ Press, Great Clarendon St, Oxford OX2 6 DP, England. The news editors report that additional informat
7/6/15 - Studies in the Area of Dementia Reported from University Hospital (Second-generation antipsychotic drug use in hospital inpatients with dementia: the...
Studies in the Area of Dementia Reported from University Hospital. Concerns about the drugs' safety resulted in a Medicines and Healthcare Products Regulatory Agency warning against their use in March 2009. " Our news journalists obtained a quote from the research from University Hospital, "Second-generation antipsychotic drug use was determined am
7/6/15 - The FDA Drug Approval Process Seminar: London, United Kingdom - 10th, 11th of September 2015
By a News Reporter-Staff News Editor at Pharma Business Week Research and Markets has announced the addition of the "The FDA Drug Approval Process Seminar" conference to their offering. It will also cover the organisation and structure of the Food and Drug Administration, recent amendments to the FDA's procedures designed to expedite the testing
7/6/15 - The Medicines Company Announces FDA Approval of KENGREAL? cangrelor as an Adjunct to Percutaneous Coronary Intervention PCI for Reducing Thrombotic...
By a News Reporter-Staff News Editor at Clinical Trials Week The Medicines Company announced the approval of KENGREAL? by the U.S. Food and Drug Administration as an adjunctive therapy to percutaneous coronary intervention for reducing periprocedural thrombotic events in patients who have not been treated with a P2Y12 inhibitor and are not bein
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2015 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415